Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
September 7, 2021
GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins
Laurence Booth, Cameron West, Robert P Moore, et al.
Oncotarget
|
February 8, 2024
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells
Michael R Booth, Laurence Booth, Jane L Roberts, et al.
Oncotarget
|
January 17, 2022
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
Laurence Booth, Cameron West, Robert P Moore, et al.
Oncotarget
|
February 9, 2022
GZ17-6.02 and axitinib interact to kill renal carcinoma cells
Laurence Booth, Cameron West, Robert P Moore, et al.
Journal of Opioid Management
|
January 29, 2011
Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS
Bridgit Crews, Sergey Latyshev, Charles Mikel, et al.
Patient Preference and Adherence
|
March 2, 2012
The effect of reminder systems on patients' adherence to treatment
Sarah D Fenerty, Cameron West, Scott A Davis, et al.
Therapeutic Drug Monitoring
|
November 26, 2009
LC-MS/MS extends the range of drug analysis in pain patients
Charles Mikel, Perla Almazan, Robert West, et al.
Therapeutic Drug Monitoring
|
November 26, 2009
Anomalous observations of codeine in patients on morphine
Robert West, Bridgit Crews, Charles Mikel, et al.
Therapeutic Drug Monitoring
|
September 12, 2009
6-Acetylmorphine detected in the absence of morphine in pain management patients
Bridgit Crews, Charles Mikel, Sergey Latyshev, et al.
Pain Physician
|
May 25, 2010
An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients
Amadeo Pesce, Murray Rosenthal, Robert West, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
September 7, 2021
GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins
Laurence Booth, Cameron West, Robert P Moore, et al.
Oncotarget
|
February 8, 2024
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells
Michael R Booth, Laurence Booth, Jane L Roberts, et al.
Oncotarget
|
January 17, 2022
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
Laurence Booth, Cameron West, Robert P Moore, et al.
Oncotarget
|
February 9, 2022
GZ17-6.02 and axitinib interact to kill renal carcinoma cells
Laurence Booth, Cameron West, Robert P Moore, et al.
Journal of Opioid Management
|
January 29, 2011
Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS
Bridgit Crews, Sergey Latyshev, Charles Mikel, et al.
Patient Preference and Adherence
|
March 2, 2012
The effect of reminder systems on patients' adherence to treatment
Sarah D Fenerty, Cameron West, Scott A Davis, et al.
Therapeutic Drug Monitoring
|
November 26, 2009
LC-MS/MS extends the range of drug analysis in pain patients
Charles Mikel, Perla Almazan, Robert West, et al.
Therapeutic Drug Monitoring
|
November 26, 2009
Anomalous observations of codeine in patients on morphine
Robert West, Bridgit Crews, Charles Mikel, et al.
Therapeutic Drug Monitoring
|
September 12, 2009
6-Acetylmorphine detected in the absence of morphine in pain management patients
Bridgit Crews, Charles Mikel, Sergey Latyshev, et al.
Pain Physician
|
May 25, 2010
An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients
Amadeo Pesce, Murray Rosenthal, Robert West, et al.
Page
of 5